---
title: "Healthcare Global Enterprises Ltd (HCG) — Share Price, Financials & Analysis"
symbol: "HCG"
company: "Healthcare Global Enterprises Ltd"
canonical: "https://tapetide.com/stocks/HCG"
isin: "INE075I01017"
nse_symbol: "HCG"
bse_code: "539787"
sector: "Healthcare Services"
industry: "Hospitals"
market_cap_cr: 10342.16
generated_at: "2026-09-13T18:45:13.876Z"
---

# Healthcare Global Enterprises Ltd (HCG)

Canonical page: https://tapetide.com/stocks/HCG

## Company

- **NSE Symbol:** HCG
- **BSE Code:** 539787
- **ISIN:** INE075I01017
- **Sector:** Healthcare Services
- **Industry:** Hospitals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2016-03-30
- **CEO:** Manisha Kumar
- **Employees:** 6736
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** hcgoncology.com

## About

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]

## Latest Price

- **Price:** ₹693.9
- **Change:** -7 (-1%)
- **Open:** ₹700.9
- **Day High:** ₹700.9
- **Day Low:** ₹691.3
- **Previous Close:** ₹700.9
- **Volume:** 44421
- **As Of:** 2026-09-11T10:23:06+00:00

## Key Fundamentals

Observed at 2026-09-11T04:42:53.920176Z.

- **Market Cap:** ₹10342.16 Cr
- **Classification:** Microcap
- **P/E (reported):** 315.9
- **P/E (TTM):** 453.53
- **EPS (TTM):** ₹1.53
- **EPS (reported):** ₹3.57
- **Book Value:** ₹89.21
- **Price to Book:** 7.9
- **Dividend Yield:** 0%
- **ROE:** 1.61%
- **ROCE:** 7%
- **Debt to Equity:** 1.3
- **Revenue (yearly):** ₹2570.4 Cr
- **Net Income:** ₹22.8 Cr
- **EBITDA:** ₹490.8 Cr
- **52-Week High:** ₹799.71
- **52-Week Low:** ₹513.3
- **RSI (14):** 49.97

## Tapetide Score

- **Score:** 40 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Flat
- **Percentile:** 14.5 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 11.42 | 9% |
| growth | 43.71 | 9% |
| momentum | 52.84 | 12% |
| ownership | 56.07 | 24% |
| quality | 47.57 | 22% |
| valuation | 19.54 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Stock is trading at 7.78 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company has a low return on equity of 4.24% over last 3 years.
- Promoter holding has decreased over last 3 years: -7.14%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 9.45% | 21.97% | 57.68% |
| ebitda margin growth | 27.6% | 2.09% | 6.29% | 7.43% |
| net income growth | 312.5% | -53.28% | -1% | 18% |
| revenue growth | 6.42% | 13.85% | 14% | 20% |
| roce | 47.67% | -17.36% | -22.14% | 8.71% |
| roe | 307.43% | -67.34% | 3.77% | -63.41% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 487 | 470 | 495 | 526 | 554 | 559 | 585 | 613 | 647 | 633 | 652 | 695 |
| Expenses | 402 | 391 | 403 | 435 | 451 | 470 | 480 | 505 | 524 | 524 | 527 | 573 |
| Operating Profit | 85 | 79 | 92 | 91 | 102 | 88 | 106 | 108 | 123 | 110 | 125 | 122 |
| OPM % | 17 | 17 | 19 | 17 | 18 | 16 | 18 | 18 | 19 | 17 | 19 | 18 |
| Other Income | 3 | 6 | 9 | 9 | 11 | 6 | 10 | 8 | 3 | -10 | -18 | 13 |
| Interest | 27 | 29 | 27 | 34 | 36 | 41 | 44 | 45 | 44 | 45 | 43 | 40 |
| Depreciation | 43 | 44 | 46 | 47 | 50 | 57 | 58 | 58 | 63 | 61 | 63 | 70 |
| Profit before tax | 18 | 11 | 28 | 19 | 28 | -3 | 14 | 12 | 20 | -6 | 1 | 25 |
| Tax % | 40 | 69 | 17 | 28 | 25 | -335 | 50 | 50 | -4 | 30 | -223 | 34 |
| Net Profit | 11 | 3 | 23 | 14 | 21 | 8 | 7 | 6 | 21 | -8 | 4 | 16 |
| EPS in Rs | 0.92 | 0.39 | 1.44 | 0.82 | 1.22 | 0.47 | 0.5 | 0.32 | 1.09 | -0.63 | 0.15 | 0.92 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 829 | 976 | 1092 | 1009 | 1395 | 1691 | 1908 | 2218 | 2538 | 2627 |
| Expenses | 713 | 864 | 936 | 887 | 1161 | 1394 | 1581 | 1835 | 2080 | 2147 |
| Operating Profit | 116 | 112 | 157 | 122 | 234 | 297 | 327 | 384 | 459 | 480 |
| OPM % | 14 | 11 | 14 | 12 | 17 | 18 | 17 | 17 | 18 | 18 |
| Other Income | 25 | 10 | 10 | -72 | 110 | 15 | 24 | 39 | -11 | -13 |
| Interest | 42 | 70 | 138 | 119 | 98 | 104 | 109 | 155 | 177 | 171 |
| Depreciation | 71 | 85 | 148 | 159 | 158 | 163 | 174 | 211 | 244 | 257 |
| Profit before tax | 27 | -33 | -119 | -229 | 88 | 45 | 68 | 57 | 27 | 40 |
| Tax % | 38 | -7 | 5 | -3 | 56 | 61 | 39 | 14 | 15 | — |
| Net Profit | 17 | -31 | -125 | -221 | 39 | 18 | 41 | 49 | 23 | 33 |
| EPS in Rs | 2.23 | -2.66 | -11.36 | -14.58 | 3.65 | 1.99 | 3.27 | 3.01 | 0.92 | 1.53 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 86 | 87 | 88 | 89 | 125 | 139 | 139 | 139 | 139 | 149 |
| Reserves | 347 | 428 | 389 | 293 | 572 | 731 | 721 | 686 | 783 | 1183 |
| Borrowings | 420 | 464 | 658 | 1347 | 977 | 915 | 901 | 1274 | 1837 | 1735 |
| Other Liabilities | 372 | 461 | 515 | 518 | 357 | 433 | 549 | 601 | 780 | 853 |
| Total Liabilities | 1225 | 1440 | 1650 | 2246 | 2031 | 2218 | 2311 | 2701 | 3540 | 3920 |
| Fixed Assets | 685 | 828 | 970 | 1646 | 1382 | 1547 | 1553 | 1758 | 2442 | 2462 |
| CWIP | 148 | 174 | 153 | 46 | 30 | 22 | 18 | 83 | 25 | 19 |
| Investments | 11 | 53 | 49 | 34 | 26 | 9 | 10 | 10 | 11 | 14 |
| Other Assets | 381 | 385 | 478 | 520 | 593 | 641 | 730 | 850 | 1062 | 1426 |
| Total Assets | 1225 | 1440 | 1650 | 2246 | 2031 | 2218 | 2311 | 2701 | 3540 | 3920 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 91 | 98 | 98 | 130 | 121 | 220 | 252 | 285 | 317 | 347 |
| Cash from Investing Activity | -210 | -283 | -238 | -101 | -171 | 125 | -133 | -226 | -488 | -177 |
| Cash from Financing Activity | 89 | 161 | 84 | -58 | 112 | -155 | -140 | -64 | -42 | 241 |
| Net Cash Flow | -29 | -24 | -56 | -30 | 62 | 190 | -22 | -5 | -213 | 410 |
| Free Cash Flow | -101 | -158 | -90 | 23 | 85 | 150 | 126 | 101 | 110 | 59 |
| CFO/OP | 93 | 88 | 121 | 100 | 68 | 104 | 92 | 101 | 91 | 83 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 54 | 57 | 59 | 62 | 67 | 57 | 65 | 56 | 66 | 60 |
| Inventory Days | 40 | 46 | 45 | 35 | 32 | 31 | 33 | 33 | 33 | 32 |
| Days Payable | 272 | 274 | 303 | 234 | 221 | 199 | 214 | 216 | 210 | 185 |
| Cash Conversion Cycle | -178 | -171 | -200 | -136 | -121 | -112 | -116 | -127 | -111 | -93 |
| Working Capital Days | -112 | -74 | -110 | -102 | -26 | -43 | -40 | -70 | -91 | -61 |
| ROCE % | 7 | 6 | 3 | 1 | -1 | 5 | 8 | 9 | 9 | 8 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 71.3% | 71.29% | 71.28% | 71.25% | 71.23% | 71.23% | 71.22% | 62.46% | 63.78% | 63.77% | 64.21% | 64.21% |
| FIIs | 6.28% | 6.37% | 6.74% | 3.95% | 4.29% | 2.77% | 2.45% | 2.16% | 3.59% | 3.22% | 2.75% | 2.74% |
| DIIs | 7.94% | 6.66% | 8.52% | 10.89% | 11.64% | 12.94% | 12.47% | 13.22% | 18.36% | 18.3% | 18.91% | 19.2% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 9.96% | 9.68% | 9.39% | 9.41% | 9.33% | 9.6% | 10.43% | 10.5% | 10.41% | 11.2% | 10.79% | 10.83% |
| Others | 4.52% | 6% | 4.07% | 4.49% | 3.5% | 3.46% | 3.43% | 11.66% | 3.86% | 3.51% | 3.34% | 3.02% |
| No. of Shareholders | 27327 | 27289 | 27195 | 26529 | 29670 | 32820 | 45394 | 47028 | 46970 | 45366 | 47576 | 48905 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 9 / 4 / 6

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 702.65 | Sell |
| EMA (10) | 701.44 | Sell |
| SMA (20) | 710.01 | Sell |
| EMA (20) | 702.71 | Sell |
| SMA (50) | 689.42 | Buy |
| EMA (50) | 687.7 | Buy |
| SMA (100) | 655.08 | Buy |
| EMA (100) | 664.72 | Buy |
| SMA (200) | 634.76 | Buy |
| EMA (200) | 640.65 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 47.7 | Neutral |
| MACD (12,26,9) | 1.36 | Sell |
| Stochastic (14,3,3) | 26.31 | Neutral |
| ADX (14) | 28.54 | Buy |
| Williams %R (14) | -82.38 | Buy |
| ATR (14) | 24.12 | High Volatility |
| ROC (12) | -1.73 | Sell |
| Stoch RSI (14) | 14.53 | Buy |
| UO (7,14,28) | 42.16 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 7 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |

Based on 7 analyst ratings, observed at 2026-09-11T04:42:55.273962+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Intimation Of Grant Of Employee Stock Options Under Healthcare Global Enterprises Limited- Employee Stock Option Scheme 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c3107fd-4d4a-416a-b2c3-2ff3d96f6615.pdf) |
| 2026-08-28 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad263c23-00f5-4f1e-ac0e-73bed4b9904e.pdf) |
| 2026-08-28 | [Letter To Members Of The Company Containing Weblink And Path Of Integrated Annual Report For The Financial Year 2025-26.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03662c15-cc4a-49db-a686-ebd3c21e0906.pdf) |
| 2026-08-27 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39c6c4eb-b592-45d6-b9c6-af553e9da584.pdf) |
| 2026-08-27 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae050326-a641-41b2-b1b3-8739f58770da.pdf) |
| 2026-08-27 | [Notice Of 28Th Annual General Meeting Of The Company For FY 2025-26.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e57462f-b873-4520-8d8e-f3628c87f739.pdf) |
| 2026-08-25 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d08b15e2-747d-4a7c-addd-ee715d8caa45.pdf) |
| 2026-08-08 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a849dc7-02b8-4fa7-b268-d327f424ce0d.pdf) |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=baf7ce51-0b47-4407-af1c-502237ea5f45.pdf) |
| 2026-08-06 | [Board Meeting Outcome for Outcome Of Board Meeting- August 06 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f15b6c4-acf0-4a91-8c0a-7a9074f6f570.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a460df04-053d-4497-8c84-26dd98ea47a7.pdf) |
| 2026-02-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17e2b542-4587-420a-b3a1-8d4d78004dcd.pdf) |
| 2025-12-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09db8266-46b1-41c8-90ca-7c2084eb10d8.pdf) |
| 2025-05-30 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6f14792-9ce8-4c61-8e47-07d8a82644bb.pdf) |
| 2025-03-06 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8b81c48-e01f-48a4-98c4-b270b8711902.pdf) |
| 2024-11-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e09ad94c-bc8f-48b2-8964-c54b54e57588.pdf) |
| 2024-08-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddb1bcb4-d3d2-4235-ab80-1388fda7be94.pdf) |
| 2024-06-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70a51fa5-c12b-4a4a-93fa-643c1f84ffa5.pdf) |
| 2024-02-16 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71ce8ad1-4a64-4e85-b704-b3bc98b94f0c.pdf) |
| 2023-11-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ff4653f-746a-4b36-a476-523104b11e5b.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=154a9906-63cc-4a62-ade6-9b5171944c72.pdf) |
| 2026-05-20 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1be43bd-e1bb-4a58-9c1a-d88615e70ee1.pdf) |
| 2026-02-09 | [Audio Recording Of The Investor/Analyst Meet Held On February 09 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81dcfef5-c3a7-4670-aedf-0720ab660828.pdf) |
| 2025-12-04 | [Audio Recording Of The Virtual Investor & Analyst Meet Held On December 04 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87b4e629-5e40-4699-a09c-62852853f91d.pdf) |
| 2025-05-26 | [Earnings Call Held With Analysts/Investors To Discuss The Audited Financial Results Of The Quarter And Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1ec8b04-73b6-4552-b7ef-f5e17aae3ecc.pdf) |
| 2024-08-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1faaa0b-9131-42a1-b5fb-4d3e49165aa2.pdf) |
| 2023-08-11 | [Announcement Under Regulation 30- Earnings Call Recording](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cd6f499-afbe-4c9b-bc63-65fe88e68b52.pdf) |
| 2023-02-09 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efc40666-d7a1-4cc4-93b7-61fabe8409b5.pdf) |
| 2022-11-11 | [Earnings Call Held With Analysts/Investors To Discuss The Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd789a01-44ba-4e56-b1f6-2bb886d1f834.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-06 | [Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23b8ad6d-3e29-43c7-a1c6-5a3373ac186b.pdf) |
| 2026-05-19 | [Audited Financial Results For The Quarter And Year Ended March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b77897ee-f641-4170-8565-9d0ee377b94e.pdf) |
| 2026-02-05 | [Unaudited Financial Results Of The Company (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc8f43d8-359b-495b-bab9-62d582049bd0.pdf) |
| 2025-11-12 | [Unaudited Financial Results Of The Company (Standalone And Consolidated) For The Quarter And Six Months Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d914a1f-8cfb-4bf3-a86b-b3bd83bb86c3.pdf) |
| 2025-08-01 | [Results-Financial Results For Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=677d9feb-07fb-47a2-a32c-f84a90a446c8.pdf) |
| 2025-02-14 | [Results- Financial Results For Decembe 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6fbc7bf-2e72-4da5-b5f2-df2115e75ca3.pdf) |
| 2024-11-09 | [Results - Financial Results For September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d975144-eb30-44fc-adac-2dca29eca636.pdf) |
| 2024-08-08 | [Results - Financial Results For June 30 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfacdd9a-5e69-498d-8b4f-34f49d9d8cba.pdf) |
| 2024-05-29 | [Results For The Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73cd7de9-5cd4-4c8a-89cf-529cb6dc14ea.pdf) |
| 2024-02-08 | [Results - Financial Results For The Quarter And Nine Months Ended December 31, 2023.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7526a0d2-6140-4cfa-8ce2-ac1234aa6377.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ceb00c6b-5886-4c6f-9feb-f0573eb9c39f.pdf) |
| 2026-05-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5789477d-6094-4739-a842-92ce27b2f81a.pdf) |
| 2026-02-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c71f650-202b-451d-bffd-ae3fb07819c5.pdf) |
| 2026-02-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50370b44-929f-4234-a47f-1e6e96617d08.pdf) |
| 2025-12-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=430cd158-2719-493f-b598-501d359f9ff8.pdf) |
| 2025-11-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1f48fbc-c860-47ef-8a58-107bd50c57b2.pdf) |
| 2025-08-01 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4091bc49-4ef8-483b-8033-988cb7567173.pdf) |
| 2025-05-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5fa4ecd-3b95-4221-9a19-60f8be54c52c.pdf) |
| 2025-02-16 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=baeed4ce-6512-49f1-afe6-ea55a80e0c59.pdf) |
| 2024-11-09 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f12a6717-a86c-4619-b51e-3d0357d3ad95.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - HCG Tanzania wound up effective March 2, 2026; formal notice received March 26; non-operational, no consideration. | [Intimation Regarding Winding Up Of Healthcare Global (Tanzania) Private Limited, Wholly Owned Indirect Subsidiary Of The Company 9h - HCG Tanzania wound up effective March 2, 2026; formal notice received March 26; non-operational, no consideration.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8ae6cde5-f655-4626-9d74-365bf6f33734.pdf) |
| 8 May - Motilal Oswal Mutual Fund sold 5,19,430 HCG shares on May 4, 2026; stake fell to 2.8646%. | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 8 May - Motilal Oswal Mutual Fund sold 5,19,430 HCG shares on May 4, 2026; stake fell to 2.8646%.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/14EB547A_1682_47A0_8C52_C42984DE8442_102011.pdf) |
| 7 May - Stock Exchanges dated May 01, 2026, with respect to the meeting of the Board of the Company, to be held on Tuesday, May 19, 2026, … | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 7 May - Stock Exchanges dated May 01, 2026, with respect to the meeting of the Board of the Company, to be held on Tuesday, May 19, 2026, …](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8b14bfc4-393e-4453-b0ab-609cbce2effe.pdf) |
| 6 Mar - Newspaper publication of advertisements in respect of certain matters relating to the Rights Issue of equity shares of the Company | [Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Mar - Newspaper publication of advertisements in respect of certain matters relating to the Rights Issue of equity shares of the Company](https://www.bseindia.com/xml-data/corpfiling/AttachHis/02dc1fb9-b942-423c-b264-6a306bf99a5a.pdf) |
| 5h - Allotment of 8,294,566 shares at ₹512; rights issue closed March 25, 2026. | [Announcement under Regulation 30 (LODR)-Allotment 5h - Allotment of 8,294,566 shares at ₹512; rights issue closed March 25, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b5c84fdb-93ec-4ea4-a07b-ec40910f73a2.pdf) |
| 4h - Allotment of 8,294,566 shares at ₹512 on March 27; paid-up shares now 14,93,02,203. | [Outcome Of Rights Issue Committee- March 27, 2026 4h - Allotment of 8,294,566 shares at ₹512 on March 27; paid-up shares now 14,93,02,203.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a42c2ca7-5812-4919-b235-6ade8ea462fc.pdf) |
| 30 Mar - Newspaper Advertisements in respect of certain matters such as details of subscription, basis of allotment and date of credit of equity shares pursuant to the … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 30 Mar - Newspaper Advertisements in respect of certain matters such as details of subscription, basis of allotment and date of credit of equity shares pursuant to the …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f9163a53-9e8d-4b25-b78e-76678d1b9789.pdf) |
| 30 Mar - Newspaper Advertisement in respect of Special Window for Transfer and Dematerialization of Physical Securities of the Company. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 30 Mar - Newspaper Advertisement in respect of Special Window for Transfer and Dematerialization of Physical Securities of the Company.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/09c1a46e-efbd-453e-a556-d178bc8302ed.pdf) |
| 30 Mar - Board approved INR 98 Cr to HCG NCHRI LLP; INR 155.66 Cr to acquire 34% in Vizag Hospital. | [Announcement under Regulation 30 (LODR)-Acquisition 30 Mar - Board approved INR 98 Cr to HCG NCHRI LLP; INR 155.66 Cr to acquire 34% in Vizag Hospital.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/98e92e85-1c02-4afe-b843-83eae77c8c2c.pdf) |
| 29 Mar - Second amendment extends second closing by three weeks; acquisition of further 34% stake in Vizag Hospital. | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements 29 Mar - Second amendment extends second closing by three weeks; acquisition of further 34% stake in Vizag Hospital.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a97ac7af-294f-42a9-a4c2-3121b3c792d5.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2022 | [Concall - Sep 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/817a0085-50f2-420c-b847-f240567d8a6f.pdf) |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81ba30d3-c73d-4b10-b818-33d7899270cf.pdf) |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/81ba30d3-c73d-4b10-b818-33d7899270cf.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e1f48fbc-c860-47ef-8a58-107bd50c57b2.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e09ad94c-bc8f-48b2-8964-c54b54e57588.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8ff4653f-746a-4b36-a476-523104b11e5b.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3ddc1b03-e344-450a-9785-daee0ad04cb1.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/343ebcd6-9ea6-4fba-9769-c1f4c3857aba.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d14639f-8db9-44e5-a378-22bb7b4c9754.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8d14639f-8db9-44e5-a378-22bb7b4c9754.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/52337fa7-5286-4eeb-9dec-f7a2008c9f27.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ab592819-a130-44f5-9161-0d2db63de4e1.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/43cb1973-d10a-4b63-9950-8bfcf7c09e39.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:45:13.876Z.